Cargando…

Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

Detalles Bibliográficos
Autores principales:	Brekman, Angelika, Singh, Kathryn E, Polotskaia, Alla, Kundu, Nandini, Bargonetti, Jill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446369/ http://dx.doi.org/10.1186/bcr3130

Ejemplares similares

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2011)

Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway
por: Kundu, Nandini, et al.
Publicado: (2017)

Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death
por: Rosso, Melissa, et al.
Publicado: (2015)

Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator
por: Okoro, Danielle R., et al.
Publicado: (2013)

Impedimetric Detection of Mutant p53 Biomarker-Driven Metastatic Breast Cancers under Hyposmotic Pressure
por: Shi, Menglu, et al.
Publicado: (2014)

Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient
por: Shtraizent, Nataly, et al.
Publicado: (2015)

Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
por: Gao, Chong, et al.
Publicado: (2019)

Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
por: Qiu, Wei-Gang, et al.
Publicado: (2017)

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
por: Bianco, Gaia, et al.
Publicado: (2022)

DNA Adducts of Decarbamoyl Mitomycin C Efficiently Kill Cells without Wild-Type p53 Resulting from Proteasome-Mediated Degradation of Checkpoint Protein 1
por: Boamah, Ernest K., et al.
Publicado: (2010)

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis
por: Gao, Chong, et al.
Publicado: (2019)

Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer
por: Swetzig, Wendy M., et al.
Publicado: (2016)

Correction: Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2013)

Correction: The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise
Publicado: (2015)

MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
por: Qi, Dong-Lai, et al.
Publicado: (2016)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

Correction: MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity
por: Chinnam, Meenalakshmi, et al.
Publicado: (2022)

MDM2-C Functions as an E3 Ubiquitin Ligase
por: Kim, Jun Yeob, et al.
Publicado: (2020)

Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J., et al.
Publicado: (2018)

Correction to: MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
por: Tang, Jianing, et al.
Publicado: (2022)

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021)

Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
Publicado: (2023)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction
por: Xiao, Gu, et al.
Publicado: (2015)

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2018)

Mdmx promotes genomic instability independent of p53 and Mdm2
por: Carrillo, Alexia M., et al.
Publicado: (2014)

Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
por: Zhao, Kai, et al.
Publicado: (2019)

Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53
por: Saleh, Mansoor N., et al.
Publicado: (2022)

Correction: Estrogen Induces Global Reorganization of Chromatin Structure in Human Breast Cancer Cells
Publicado: (2015)

Correction: Estrogenicity of Glabridin in Ishikawa Cells
por: Su Wei Poh, Melissa, et al.
Publicado: (2015)

Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
por: Di Leva, Gianpiero, et al.
Publicado: (2013)

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
por: Qin, Jiang-Jiang, et al.
Publicado: (2017)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

Correction: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
por: Colditz, Graham A
Publicado: (2007)

Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status
por: Lama, Rati, et al.
Publicado: (2022)

Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing
por: Sahin, Ilyas, et al.
Publicado: (2020)

MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014)

Correction to: Bone health in estrogen-free contraception
por: Hadji, P., et al.
Publicado: (2020)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

Correction to: Supporting independence at home for people living with dementia: a qualitative ethnographic study of homecare
por: Leverton, Monica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0dlold24srtb9b7msv4au5cl1d